Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cell Therapy Market, by Therapy Type
1.4.2 Europe Cell Therapy Market, by Therapeutic Area
1.4.3 Europe Cell Therapy Market, by End User
1.4.4 Europe Cell Therapy Market, by Cell Type
1.4.5 Europe Cell Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Europe Cell Therapy Market by Therapy Type
4.1 Europe Autologous Market by Country
4.2 Europe Allogeneic Market by Country
Chapter 5. Europe Cell Therapy Market by Therapeutic Area
5.1 Europe Malignancies Market by Country
5.2 Europe Autoimmune Disorders Market by Country
5.3 Europe Musculoskeletal Disorders Market by Country
5.4 Europe Dermatology Market by Country
5.5 Europe Other Therapeutic Area Market by Country
Chapter 6. Europe Cell Therapy Market by End User
6.1 Europe Academic & Research Institutes Market by Country
6.2 Europe Hospitals & Clinics Market by Country
Chapter 7. Europe Cell Therapy Market by Cell Type
7.1 Europe Stem Cell Market by Country
7.2 Europe Umbilical Cord-Derived Cell Market by Country
7.3 Europe Adipose-Derived Stem Cell Market by Country
7.4 Europe Non-Stem Cell Market by Country
7.5 Europe Bone Marrow Cell Market by Country
7.6 Europe Blood Cell Market by Country
7.7 Europe Others Cell Market by Country
Chapter 8. Europe Cell Therapy Market by Country
8.1 Germany Cell Therapy Market
8.1.1 Germany Cell Therapy Market by Therapy Type
8.1.2 Germany Cell Therapy Market by Therapeutic Area
8.1.3 Germany Cell Therapy Market by End User
8.1.4 Germany Cell Therapy Market by Cell Type
8.2 UK Cell Therapy Market
8.2.1 UK Cell Therapy Market by Therapy Type
8.2.2 UK Cell Therapy Market by Therapeutic Area
8.2.3 UK Cell Therapy Market by End User
8.2.4 UK Cell Therapy Market by Cell Type
8.3 France Cell Therapy Market
8.3.1 France Cell Therapy Market by Therapy Type
8.3.2 France Cell Therapy Market by Therapeutic Area
8.3.3 France Cell Therapy Market by End User
8.3.4 France Cell Therapy Market by Cell Type
8.4 Russia Cell Therapy Market
8.4.1 Russia Cell Therapy Market by Therapy Type
8.4.2 Russia Cell Therapy Market by Therapeutic Area
8.4.3 Russia Cell Therapy Market by End User
8.4.4 Russia Cell Therapy Market by Cell Type
8.5 Spain Cell Therapy Market
8.5.1 Spain Cell Therapy Market by Therapy Type
8.5.2 Spain Cell Therapy Market by Therapeutic Area
8.5.3 Spain Cell Therapy Market by End User
8.5.4 Spain Cell Therapy Market by Cell Type
8.6 Italy Cell Therapy Market
8.6.1 Italy Cell Therapy Market by Therapy Type
8.6.2 Italy Cell Therapy Market by Therapeutic Area
8.6.3 Italy Cell Therapy Market by End User
8.6.4 Italy Cell Therapy Market by Cell Type
8.7 Rest of Europe Cell Therapy Market
8.7.1 Rest of Europe Cell Therapy Market by Therapy Type
8.7.2 Rest of Europe Cell Therapy Market by Therapeutic Area
8.7.3 Rest of Europe Cell Therapy Market by End User
8.7.4 Rest of Europe Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
